TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33741044

Group type: EXPERIMENTAL
Intervention: VIPP-SD intervention (Video-feedback to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: VIPP-SD intervention
Number of subjects: 202
Study: 36413635

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CB)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RF)
Number of subjects: 230
Study: 33443915

Group type: EXPERIMENTAL
Intervention: Twice‐daily application of a commercially available skin and body lotion to the arms and legs of participants
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no moisturizer application)
Number of subjects: 128
Study: 32841300

Group type: EXPERIMENTAL
Intervention: Plyometric exercise (PLYO)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Traditional resistance training (RT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Walking (WALK)
Number of subjects: 40
Study: 35139725

Group type: COMPARATOR
Intervention: Reirradiation and hyperthermia (standard arm)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Reirradiation and hyperthermia plus cisplatin (combined arm)
Number of subjects: 49
Study: 34062589

Group type: EXPERIMENTAL
Intervention: Team-based treatment (blended collaborative care) in secondary prevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive psychology and mindfulness training
Number of subjects: 0
Study: 34314877

Group type: EXPERIMENTAL
Intervention: YouTube-delivered aerobic and muscle-strengthening PA videos
Number of subjects: 64

Group type: COMPARATOR
Intervention: General health education videos (Control)
Number of subjects: 64
Study: 33744043

Group type: EXPERIMENTAL
Intervention: BUZZY® vibratory stimulation tool (switched on before injection)
Number of subjects: 118
Study: 35014215

Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) intervention consisting of aerobic and resistance exercises, moderate intensity, delivered at two sessions per week for 9 months.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Adapted physical activity (APA) intervention.
Number of subjects: 61
Study: 33264556

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 11330

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 11330

Group type: EXPERIMENTAL
Intervention: Lopinavir
Number of subjects: 11330

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 11330

Group type: COMPARATOR
Intervention: Control (no trial drug)
Number of subjects: 11330
Study: 33988659

Group type: EXPERIMENTAL
Intervention: GSH-1 (1 mM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GSH-1 (1 mM) with ET-0
Number of subjects: 60

Group type: COMPARATOR
Intervention: GSH-0 (0 mM) and GSH-1 (1 mM)
Number of subjects: 60
Study: 35863686

Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy (AI)
Number of subjects: 3059

Group type: COMPARATOR
Intervention: Conventional colonoscopy (CC)
Number of subjects: 3059
Study: 34582373

Group type: EXPERIMENTAL
Intervention: Insulin Degludec
Number of subjects: 50

Group type: COMPARATOR
Intervention: Insulin Glargine
Number of subjects: 50
Study: 34958366

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 4588

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4588
Study: 33229279

Group type: EXPERIMENTAL
Intervention: Vignette conditions describing reproductively challenged women
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: General access to ART
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Personal funds to assist women with access to ART
Number of subjects: 554
Study: 33019981

Group type: EXPERIMENTAL
Intervention: Decrease in SMI (ΔSMI) during NACT
Number of subjects: 212

Group type: COMPARATOR
Intervention: Stable/increase in SMI (ΔSMI) during NACT
Number of subjects: 212
Study: 35141339

Group type: EXPERIMENTAL
Intervention: Single-stage surgery (arthroscopic microfracture and modified Broström‐Gould procedure simultaneously)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Staged surgery (arthroscopic debridement of OLT and microfracture followed by rehabilitation, then modified Broström‐Gould procedure)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Single-stage surgery
Number of subjects: 103

Group type: COMPARATOR
Intervention: Staged surgery
Number of subjects: 103
Study: 616037435

Group type: EXPERIMENTAL
Intervention: Korean traditional music (KTM) played during surgery on the first eye
Number of subjects: 52

Group type: COMPARATOR
Intervention: No music (control group) during surgery on the second eye
Number of subjects: 52
Study: 34609939

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 34343292

Group type: EXPERIMENTAL
Intervention: 60 µg/day of D3 for 8 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 µg/day of 25(OH)D3 for 8 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: D3 or 25(OH)D3 supplementation
Number of subjects: 18
Study: 33228174

Group type: EXPERIMENTAL
Intervention: Exercise for Health intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35331677

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (4 g of magnesium sulphate heptahydrate, 8 mmol magnesium ions)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 109
Study: 33714901

Group type: EXPERIMENTAL
Intervention: Healthy Recovery intervention (8-session group-based intervention targeting smoking, diet, and physical inactivity)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Healthy Recovery intervention
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 151
Study: 32568845

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 210

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Natural killer cell activity
Number of subjects: 210
Study: 35248289

Group type: EXPERIMENTAL
Intervention: Alexander Technique (performed in three 60-min sessions per week for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care for LBP patients (Control group)
Number of subjects: 80
Study: 33963742

Group type: EXPERIMENTAL
Intervention: Stable liquid droplets (LS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Acid-unstable emulsions (SU)
Number of subjects: 15
Study: 32588926

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brentuximab vedotin
Number of subjects: 0
Study: 35227800

Group type: EXPERIMENTAL
Intervention: Endovascular aortic repair (EVAR)
Number of subjects: 31471
Study: 35233749

Group type: EXPERIMENTAL
Intervention: Implementation-intention intervention (IG)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Active control group (CG)
Number of subjects: 69
Study: 32182434

Group type: EXPERIMENTAL
Intervention: ATP training (TOJ) over 14 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: Non-ATP training (intensity discrimination) over 14 days
Number of subjects: 82

Group type: COMPARATOR
Intervention: No training
Number of subjects: 82
Study: 36165996

Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT; 7% protein, 42% fat, 52% carbohydrate)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-fat meal (FAT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-carbohydrate meal (CHO; 7% protein, 13% fat, 80% carbohydrate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High-carbohydrate meal (CHO)
Number of subjects: 10
Study: 34001020

Group type: EXPERIMENTAL
Intervention: Golf intervention (180 min training/week)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Golf intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study: 35619171

Group type: EXPERIMENTAL
Intervention: Range of motion exercises
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 33364042

Group type: EXPERIMENTAL
Intervention: High-dose vitamin A plus E supplementation (AE group, N = 36)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: High-dose vitamin A plus E with zinc (AEZ group, N = 35)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No supplements (control group, N = 27)
Number of subjects: 98
Study: 33544819

Group type: EXPERIMENTAL
Intervention: 30 mg/kg/day valproic acid orally for 14 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: No valproic acid (control)
Number of subjects: 10
Study: 32036587

Group type: EXPERIMENTAL
Intervention: BI 425809
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34783270

Group type: EXPERIMENTAL
Intervention: Strength exercises group
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Breathing exercises group
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 77
Study: 32859487

Group type: EXPERIMENTAL
Intervention: Bilateral pectointercostal fascial block using ropivacaine injection 0.25%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 40
Study: 35259633

Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Xylometazoline
Number of subjects: 519

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 519
Study: 32270017

Group type: EXPERIMENTAL
Intervention: Integrated curriculum on conflicts of interest and communication of risk
Number of subjects: 32
Study: 36156131

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 849

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 849

Group type: EXPERIMENTAL
Intervention: LCOS
Number of subjects: 849
Study: 34516497

Group type: EXPERIMENTAL
Intervention: Xianling Gubao capsule + glucosamine hydrochloride capsule simulation agent treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucosamine hydrochloride capsule + Xianling Gubao capsule simulation agent treatment
Number of subjects: 0
Study: 36912173

Group type: EXPERIMENTAL
Intervention: Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg
Number of subjects: 1125

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 1125
Study: 34288958

Group type: EXPERIMENTAL
Intervention: Kenward and Roger Wald test power approximation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Power calculation for an unbalanced group-randomized trial
Number of subjects: 0
Study: 34772901

Group type: EXPERIMENTAL
Intervention: Montmorency cherry concentrate (MCC) supplementation
Number of subjects: 10
Study: 33625064

Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir alafenamide (TAF)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Dolutegravir with emtricitabine plus tenofovir disoproxil fumarate (TDF)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 314
Study: 32305653

Group type: EXPERIMENTAL
Intervention: Mechanical debridement with adjuvant antimicrobial photodynamic therapy (aPDT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mechanical debridement alone
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mechanical debridement with and without aPDT
Number of subjects: 36
Study: 35241006

Group type: EXPERIMENTAL
Intervention: Blister packaged IFA pills
Number of subjects: 950

Group type: COMPARATOR
Intervention: Loose packaged IFA pills
Number of subjects: 950
Study: 34019802

Group type: EXPERIMENTAL
Intervention: TAK-426 2 μg
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: TAK-426 5 μg
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: TAK-426 10 μg
Number of subjects: 271

Group type: COMPARATOR
Intervention: TAK-426 10 μg vs 2 μg
Number of subjects: 271

Group type: COMPARATOR
Intervention: TAK-426 10 μg vs 5 μg
Number of subjects: 271

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 271
Study: 35384852

Group type: EXPERIMENTAL
Intervention: CuNET scale (texting-based condom negotiation)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: CuNET score increase
Number of subjects: 242
Study: 33950027

Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: PTNS or sham
Number of subjects: 165
Study: 32368027

Group type: EXPERIMENTAL
Intervention: UMEC 62.5 mcg
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: UMEC
Number of subjects: 306

Group type: COMPARATOR
Intervention: UMEC and Placebo
Number of subjects: 306
Study: 35811050

Group type: EXPERIMENTAL
Intervention: CBD-rich oil administered within the reconsolidation window
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo oil administered within the reconsolidation window
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CBD-rich oil administered outside of the reconsolidation window
Number of subjects: 99
Study: 33934618

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 1.25 IU/hour
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 2.5 IU/hour
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 5.0 IU/hour
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of 1.25 IU/hour vs 5 IU/hour
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of haemoglobin levels
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of incidence of tachycardia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of incidence of hypotension
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of incidence of nausea/vomiting
Number of subjects: 120
Study: 32109318

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid and hydroquinone 4% cream, sunscreen
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hydroquinone 4% cream, sunscreen, and placebo capsules
Number of subjects: 50
Study: 91357366

Group type: EXPERIMENTAL
Intervention: Human immune serum globulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35469409

Group type: EXPERIMENTAL
Intervention: Everolimus plus reduced tacrolimus (EVR + rTAC)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Mycophenolate mofetil plus tacrolimus (MMF + TAC)
Number of subjects: 211
Study: 34560922

Group type: COMPARATOR
Intervention: Olfactory ensheathing cell therapy
Number of subjects: 0
Study: 36056874

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg orally once daily for two weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33272965

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 2 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 6 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Ziltivekimab 20 mg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 37081779

Group type: EXPERIMENTAL
Intervention: INSIGHT Responsive Parenting Intervention
Number of subjects: 279

Group type: COMPARATOR
Intervention: Safety Control
Number of subjects: 279
Study: 32107133

Group type: EXPERIMENTAL
Intervention: Operated foramen in CSR patients
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nonoperated foramen in CSR patients
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 42
Study: 32115477

Group type: EXPERIMENTAL
Intervention: Nalmefene 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalmefene 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33309466

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Breathing Therapy
Number of subjects: 76
Study: 32282729

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Periarticular infiltration
Number of subjects: 60
Study: 33942396

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: High-dose glucocorticoids, antibiotics, and monoclonal anti-TNFα antibody
Number of subjects: 1

Group type: COMPARATOR
Intervention: Anti-PD-1 antibodies
Number of subjects: 1
Study: 32802319

Group type: EXPERIMENTAL
Intervention: TFS rehabilitation training (30-minute sessions, three times a week for five weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 30
Study: 34001373

Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents (UP-C/A)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Standard relaxation and education protocol
Number of subjects: 4
Study: 32367400

Group type: EXPERIMENTAL
Intervention: ACE D/D, 5‐HTTLPR I/I haplotype (n=46)
Number of subjects: 507

Group type: COMPARATOR
Intervention: Non-risk haplotypes (n=461)
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: ACE D/D, 5‐HTTLPR I/I haplotype
Number of subjects: 507

Group type: COMPARATOR
Intervention: Non-risk haplotypes
Number of subjects: 507
Study: 35634479

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (Group L)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Alkalised lidocaine (Group AL)
Number of subjects: 72
Study: 32568873

Group type: EXPERIMENTAL
Intervention: Indoor aerosol pollution from local cafeterias without ventilation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Children's activity during lesson breaks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Soft furniture and carpets in classrooms and corridors
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Outdoor aerosol pollution in city center schools
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intermittent sources like construction work during classes
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Use of petrol-powered lawn trimmers
Number of subjects: 11
Study: 33196927

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention including psychoeducation on PND, coping skills, healthy mother/child interaction, and infant stimulation in addition to routine treatment.
Number of subjects: 567

Group type: COMPARATOR
Intervention: Control group receiving treatment as usual.
Number of subjects: 567

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention
Number of subjects: 567
Study: 32783498

Group type: EXPERIMENTAL
Intervention: Nutrition education intervention
Number of subjects: 0
Study: 34041633

Group type: COMPARATOR
Intervention: HF-rTMS targeting DLPFC
Number of subjects: 11

Group type: COMPARATOR
Intervention: HF-rTMS targeting motor cortex
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: HF-rTMS (DLPFC and motor cortex)
Number of subjects: 11
Study: 35701334

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT), transdermal gel (Tostran, 2%), maximum daily dose of 40 mg for 12 months
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (TRT)
Number of subjects: 69
Study: 33092711

Group type: EXPERIMENTAL
Intervention: MitraClip implantation
Number of subjects: 5184
Study: 33661323

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing
Number of subjects: 245

Group type: COMPARATOR
Intervention: Non-resurfacing
Number of subjects: 245
Study: 32052372

Group type: EXPERIMENTAL
Intervention: Video Modeling + Video Feedback (VM+VF)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Video Modeling alone (VM)
Number of subjects: 25
Study: 35511060

Group type: EXPERIMENTAL
Intervention: Accelerated Resolution Therapy (ART)
Number of subjects: 0
Study: 34570527

Group type: EXPERIMENTAL
Intervention: Brief personalized feedback intervention (PFI)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 164
Study: 34729060

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33963688

Group type: EXPERIMENTAL
Intervention: Clinical model using logistic regression
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Pure imaging-based model
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Combined model (deep learning with clinical factors)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Deep learning models (with and without clinical factors)
Number of subjects: 491
Study: 35074810

Group type: EXPERIMENTAL
Intervention: COVID-19 restrictions
Number of subjects: 104
Study: 33845710

Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34132170

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 488

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 488
Study: 33308039

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 11
Study: 36372869

Group type: EXPERIMENTAL
Intervention: LDL-C level at 6 months after randomization set at a threshold of 70 mg/dl
Number of subjects: 11105

Group type: EXPERIMENTAL
Intervention: LDL-C level below 70 mg/dl
Number of subjects: 11105
Study: 35367910

Group type: EXPERIMENTAL
Intervention: Nivolumab + ipilimumab
Number of subjects: 605

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 605
Study: 33568662

Group type: EXPERIMENTAL
Intervention: Daytime napping
Number of subjects: 452633
Study: 32617061

Group type: EXPERIMENTAL
Intervention: Oral steroid therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral macrolide therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined therapy (oral steroid + macrolide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Oral steroid group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Macrolide group)
Number of subjects: 0